Clinical Trials

26 studies in Womens Health - Enterprise

  1. Determination of the Sensitivity of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions
    1. Minnesota
  2. A Phase 2, Open-Label Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
    1. Minnesota
  3. Phase II Trial of Single Agent ABT-888 With Post-Progression Therapy of ABT-888 in Combination With Carboplatin in Patients With Stage IV BRCA-associated Breast Cancer
    1. Florida
    2. Minnesota
  4. Impact of Endogenous Estrogen on Somatostatin Inhibition and Growth Hormone Rebound in Older Women
    1. Minnesota
  5. A Phase II Trial of Neoadjuvant MK-2206 in Combination With Either Anastrozole if Postmenopausal or Anastrozole and Goserelin if Premenopausal in Women With Clinical Stage 2 or 3 PIK3CA Mutant Estrogen Receptor Positive and HER2 Negative Invasive Breast Cancer
    1. Arizona
    2. Minnesota
  6. The Effect of Antidepressants and Gabapentin on Tamoxifen Pharmacokinetics: A Prospective Study
    1. Minnesota
  7. Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand
    1. Minnesota
  8. A Pilot Study Utilizing Molecular Profiling by IHC, FISH, DNA Microarray, and Reverse Phase Protein Microarray (RPMA) of Patients' Tumors to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer.
    1. Arizona
  9. Biologic Predictors of Leiomyoma Treatment Outcomes
    1. Minnesota
  10. Community Intervention to Reduce Tobacco Use Among Alaska Native Pregnant Women
    1. Minnesota
  1. 1
  2. 2
  3. 3
  4. Next

Clinical Trials

26 studies in Womens Health - Enterprise

  1. Determination of the Sensitivity of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions
    1. Minnesota
  2. A Phase 2, Open-Label Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
    1. Minnesota
  3. Phase II Trial of Single Agent ABT-888 With Post-Progression Therapy of ABT-888 in Combination With Carboplatin in Patients With Stage IV BRCA-associated Breast Cancer
    1. Florida
    2. Minnesota
  4. Impact of Endogenous Estrogen on Somatostatin Inhibition and Growth Hormone Rebound in Older Women
    1. Minnesota
  5. A Phase II Trial of Neoadjuvant MK-2206 in Combination With Either Anastrozole if Postmenopausal or Anastrozole and Goserelin if Premenopausal in Women With Clinical Stage 2 or 3 PIK3CA Mutant Estrogen Receptor Positive and HER2 Negative Invasive Breast Cancer
    1. Arizona
    2. Minnesota
  6. The Effect of Antidepressants and Gabapentin on Tamoxifen Pharmacokinetics: A Prospective Study
    1. Minnesota
  7. Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand
    1. Minnesota
  8. A Pilot Study Utilizing Molecular Profiling by IHC, FISH, DNA Microarray, and Reverse Phase Protein Microarray (RPMA) of Patients' Tumors to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer.
    1. Arizona
  9. Biologic Predictors of Leiomyoma Treatment Outcomes
    1. Minnesota
  10. Community Intervention to Reduce Tobacco Use Among Alaska Native Pregnant Women
    1. Minnesota
  1. 1
  2. 2
  3. 3
  4. Next
.

Mayo Clinic Footer